Loading clinical trials...
Loading clinical trials...
The aim of the study is to evaluate the efficacy of Alvesco in patients with persistent asthma including or excluding allergic components over 3 months, especially in the spring season. Alvesco will b...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT07301736 · Asthma
NCT06732141 · Asthma
NCT07133074 · Beta Lactam Allergy, Hematologic Malignancy
NCT06932263 · Asthma
NCT02504853 · Food Allergy, Loeys-Dietz Syndrome, and more
Nycomed Pharma GmbH
Amstetten
Nycomed Pharma GmbH
Baden
Nycomed Pharma GmbH
Bludenz
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions